FOXP3 and immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome: To develop an editing strategy that can work as a universal cure for IPEX patients, we elected to insert a functional FOXP3 cDNA within the first coding exon, to enable correction of all IPEX patients except those bearing mutations within the promoter region.22